These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 1153166

  • 21. Calcium dobesilate versus placebo in the treatment of diabetic retinopathy: a double-blind cross-over study.
    Binkhorst PG, Van Bijsterveld OP.
    Curr Ther Res Clin Exp; 1976 Sep; 20(3):283-8. PubMed ID: 822986
    [No Abstract] [Full Text] [Related]

  • 22. Treatment of blood hyperviscosity with calcium dobesilate in patients with diabetic retinopathy.
    Benarroch IS, Brodsky M, Rubinstein A, Viggiano C, Salama EA.
    Ophthalmic Res; 1985 Sep; 17(3):131-8. PubMed ID: 4011126
    [Abstract] [Full Text] [Related]

  • 23. [The plasma levels of endothelin in diabetic retinopathy and their changes after treatment with doxium].
    Zhong H, Guo L.
    Hunan Yi Ke Da Xue Xue Bao; 1997 Sep; 22(1):56-8. PubMed ID: 9868029
    [Abstract] [Full Text] [Related]

  • 24. [Results of the use of calcium dobesilate in diabetic retinopathy].
    Trutneva KV, Katsnel'son LA, Dudnikova LK, Balishanskaia TI.
    Vestn Oftalmol; 1978 Sep; (2):68-71. PubMed ID: 653927
    [No Abstract] [Full Text] [Related]

  • 25. [Decrease of vascular fragility in diabetic retinopathy through calciumdobesilate (author's transl)].
    Freyler H, Sehorst W.
    Klin Monbl Augenheilkd; 1974 Feb; 164(2):246-51. PubMed ID: 4842139
    [No Abstract] [Full Text] [Related]

  • 26. [Capillary fragility in diabetics and its modification by calcium dobesilate].
    Zabel-Langhennig R, Kulle M.
    Z Gesamte Inn Med; 1983 Dec 01; 38(23):633-6. PubMed ID: 6670338
    [Abstract] [Full Text] [Related]

  • 27. [Current dimensions of ophthalmology].
    Kutschera E.
    Wien Med Wochenschr; 1977 Nov 15; 127(21):652-5. PubMed ID: 930107
    [No Abstract] [Full Text] [Related]

  • 28. [The diabetic retinopathy in the ophthalmologic practice (author's transl)].
    Zielinski HW.
    Klin Monbl Augenheilkd; 1975 Nov 15; 167(5):715-9. PubMed ID: 1206953
    [Abstract] [Full Text] [Related]

  • 29. Calcium dobesilate attenuates vascular injury and the progression of diabetic retinopathy in streptozotocin-induced diabetic rats.
    Padilla E, Ganado P, Sanz M, Zeini M, Ruiz E, Triviño A, Ramírez AI, Salazar JJ, Ramírez JM, Rojas B, Hoz Rd, Tejerina T.
    Diabetes Metab Res Rev; 2005 Nov 15; 21(2):132-42. PubMed ID: 15386814
    [Abstract] [Full Text] [Related]

  • 30. [Calcium dobesilate].
    Reuter H.
    Z Allgemeinmed; 1975 Feb 28; 51(6):292-3. PubMed ID: 1092080
    [No Abstract] [Full Text] [Related]

  • 31. Calcium dobesilate for diabetic retinopathy: a systematic review and meta-analysis.
    Zhang X, Liu W, Wu S, Jin J, Li W, Wang N.
    Sci China Life Sci; 2015 Jan 28; 58(1):101-7. PubMed ID: 25528255
    [Abstract] [Full Text] [Related]

  • 32. Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial.
    Haritoglou C, Gerss J, Sauerland C, Kampik A, Ulbig MW, CALDIRET study group.
    Lancet; 2009 Apr 18; 373(9672):1364-71. PubMed ID: 19376452
    [Abstract] [Full Text] [Related]

  • 33. A controlled clinical trial of calcium dobesylate in the treatment of diabetic retinopathy.
    Daubresse JC, Meunier R, Dumont P.
    Diabete Metab; 1977 Mar 18; 3(1):27-30. PubMed ID: 323086
    [Abstract] [Full Text] [Related]

  • 34. Effect of calcium dobesilate on the blood-retinal barrier in early diabetic retinopathy.
    Leite EB, Mota MC, de Abreu JR, Cunha-Vaz JG.
    Int Ophthalmol; 1990 Mar 18; 14(2):81-8. PubMed ID: 2187006
    [Abstract] [Full Text] [Related]

  • 35. Effect of calcium dobesilate on blood viscosity in diabetic microangiopathy. A review.
    Barras JP, Michal M.
    Vasa; 1986 Mar 18; 15(3):200-5. PubMed ID: 3532608
    [No Abstract] [Full Text] [Related]

  • 36. [Effect of calcium dobesilate on blood hyperviscosity].
    Fortschr Med; 1979 Mar 08; 97(9):422. PubMed ID: 428880
    [No Abstract] [Full Text] [Related]

  • 37. [Effect of calcium dobesilate on progression of diabetic retinopathy].
    Haas A, Trummer G, Eckhardt M, Schmut O, Uyguner I, Pfeiffer KP.
    Klin Monbl Augenheilkd; 1995 Jul 08; 207(1):17-21. PubMed ID: 7564132
    [Abstract] [Full Text] [Related]

  • 38. Effects of medication on blood and plasma viscosity in diabetic subjects with retinopathy.
    Barras JP, Graf C.
    Horm Metab Res Suppl; 1981 Jul 08; 11():120-3. PubMed ID: 6947948
    [No Abstract] [Full Text] [Related]

  • 39. [Role of pentoxifylline retard dosage forms in the correction of hemodynamic disorders in retinal venous occlusion and diabetic retinopathy].
    Kiseleva TN, Polunin GS, Budzinskaia MV, Korzenkova LV, Andzhelova DV, Kravchuk EA, Lagutina IuM.
    Vestn Oftalmol; 2007 Jul 08; 123(4):9-14. PubMed ID: 17802753
    [Abstract] [Full Text] [Related]

  • 40. [Present-day management of the general treatment of diabetic retinopathy].
    Popa DP, Canciu G.
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1978 Jul 08; 27(2):119-21. PubMed ID: 566942
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.